|
Volumn 1, Issue 2, 2001, Pages 51-79
|
Development of herbal medicinals: A pharmaceutical perspective
|
Author keywords
Chemical and manufacturing controls; Good manufacturing practices; Herbal medicinal development; Process and analytical validation
|
Indexed keywords
ALKALOID DERIVATIVE;
ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
ARTEMISININ DERIVATIVE;
BENZODIAZEPINE DERIVATIVE;
CAMPTOTHECIN;
CHINESE DRUG;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE INHIBITOR;
ENDOPEROXIDE;
HERBACEOUS AGENT;
HORMONE DERIVATIVE;
MORPHINE;
NATURAL PRODUCT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
PACLITAXEL;
PEPTIDE DERIVATIVE;
PLANT EXTRACT;
SESQUITERPENE DERIVATIVE;
STEROID;
TERPENE DERIVATIVE;
TOPOTECAN;
TRANQUILIZER;
TUBULIN;
UNINDEXED DRUG;
ARTICLE;
CHINESE HERB;
CONTROLLED STUDY;
DRUG INDUSTRY;
DRUG ISOLATION;
DRUG MANUFACTURE;
DRUG QUALITY;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE QUALITY;
HERB;
HERBAL MEDICINE;
MEDICINAL PLANT;
NONHUMAN;
PHARMACEUTICAL CARE;
PRIORITY JOURNAL;
STANDARDIZATION;
TAXUS BREVIFOLIA;
WELLBEING;
|
EID: 0035072733
PISSN: 15228940
EISSN: None
Source Type: Journal
DOI: 10.1300/J157v01n02_06 Document Type: Article |
Times cited : (5)
|
References (14)
|